Pharmaceutical Intermediates Gastrointestinal Agents Dexlansoprazole
Dexlansoprazole, a novel proton pump inhibitor (PPI), is employed to alleviate symptoms linked to gastroesophageal reflux disease (GERD) and erosive esophagitis. Dexlansoprazole represents the R-enantiomer of Lansoprazole, which consists of both the R- and S-enantiomers in a racemic blend.
CAS: 138530-94-6
Formula: C16H14F3N3O2S
Molecular Weight: 369.36
Target: Proton Pump
click to sign in and save
2-(((4-Chloro-3-methylpyridin-2-yl)methyl)thio)-1H-benzo[d]imidazole
click to sign in and save
(4-Chloro-3-methylpyridin-2-yl)methyl acetate
click to sign in and save
(4-Chloro-3-methylpyridin-2-yl)methanol
click to sign in and save
2-(((3-Methyl-4-nitropyridin-2-yl)methyl)thio)-1H-benzo[d]imidazole